Search Results - "Gavart, S."

Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis by Cure, S., Diels, J., Gavart, S., Bianic, F., Jones, E.

“…Abstract Background and aims: To indirectly compare the efficacy of telaprevir (TVR) and boceprevir (BOC) combined with peginterferon/ribavirin α-2a/2b (PR) in…”
Get full text

Understanding the Burden of Stress Urinary Incontinence in Europe: A Qualitative Review of the Literature by Hampel, C, Artibani, W, Espuña Pons, M, Haab, F, Jackson, S, Romero, J, Gavart, S, Papanicolaou, S

“…Objective: This study was undertaken to better define the prevalence, risk factors, as well as the economic and human burden of stress urinary incontinence…”
Get full text

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment by Haro, J. M., Edgell, E. T., Jones, P. B., Alonso, J., Gavart, S., Gregor, K. J., Wright, P., Knapp, M.

“…Objective:  The objective of the European Schizophrenia Outpatient Health Outcomes (SOHO) study is to understand the comparative costs and outcomes of…”
Get full text

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS by Curtis, S, Cure, S, Gavart, S, Dearden, L, Fleischmann, J, Ouwens, M, Lee, S

Get full text

PGI1 INCIDENCE OF ANEMIA AND NEUTROPENIA FOLLOWING HCV TREATMENT INITIATION AND RELATED DRUG TREATMENT COSTS IN THE UNITED STATES by Diels, J, Gavart, S, Nuyts, G

Get full text

PGI17 HCV TREATMENT CONTINUATION RATES IN GENOTYPE 1 PATIENTS IN A REAL-WORLD SETTING IN THE UNITED STATES by Diels, J, Gavart, S, Nuyts, G

Get full text

PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis by Diels, J, Cure, S, Gavart, S

Get full text

PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients by Gavart, S, Lee, S, D'Angelo, E.R, DeMasi, R, Cure, S, Bianic, F

Get full text

1208 IMPACT OF TELAPREVIR-BASED TREATMENT REGIMENS ON FATIGUE IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES by Gavart, S, Sherman, K.E, Thai, G, Nuyts, G, McAllister, S, Beumont, M, Luo, D, Adda, N, Wright, C, Muir, A.J

Get full text

PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany by Stahmeyer, J.T, Schauer, S, Wirth, D, Fleischmann, J, Lee, S, Gavart, S, Bianic, F, Cure, S, Krauth, C

Get full text

PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients by Cure, S, Curtis, S, Bianic, F, Gavart, S, Dearden, L, Fleischmann, J, Ouwens, M, Lee, S

Get full text

PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of Il-28B Subgroup by Curtis, S, Cure, S, Bianic, F, Gavart, S, Dearden, L, Fleischmann, J, Ouwens, M, Lee, S

Get full text

PGI23 WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAÏVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES by Thal, G, Nuyts, G, Mcallister, S, Luo, D, Muir, A.J, Sherman, K.E, Adda, N, Wright, C, Beumont, M, Gavart, S

Get full text

PIN67 - Evaluation Of Resource Utilization Among Infants, Young Children And Elderly Patients Diagnosed With Rsv Infection In The United States by Wyffels, V, Smulders, M, Gavart, S, Fleischhackl, R, Mazumder, D, Gupta, N, Nguyen-Van-Tam, J

Get full text

Evaluation Of Resource Utilization Among Infants, Young Children And Elderly Patients Diagnosed With Rsv Infection In The United States by Wyffels, V, Smulders, M, Gavart, S, Fleischhackl, R, Mazumder, D, Gupta, N, Nguyen-Van-Tam, J

“…OBJECTIVES: We described health resource utilization (HRU) among infants, young children and the elderly in a large clinical database. METHODS: Using…”
Get full text

Treatment‐Seeking Behavior of Erectile Dysfunction Patients in Europe: Results of the Erectile Dysfunction Observational Study by Haro, Josep Maria, Beardsworth, Anthony, Casariego, Joaquin, Gavart, Sandra, Hatzichristou, Dimitrios, Martin‐Morales, Antonio, Schmitt, Henry, Mirone, Vincenzo, Needs, Nicola, Riley, Alan, Varanese, Lucio, Von Keitz, Alex, Kontodimas, Stathis

“…The Erectile Dysfunction Observational Study (EDOS) is a 6‐month, pan‐European prospective, observational study of health outcomes designed to assess patients’…”
Get full text

Global index of safety (GIS): a new instrument to assess drug safety: application to a prospective pharmacoepidemiological study (EFESO) by Sacristán, J.A., Gómez, J.C., Badia, X., Kind, P., Gavart, S.

Get full text

P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO) by Sacristán, J.A., Gómez, J.C., Badia, X., Kind, P., Gavart, S.

Get full text

P02.316 Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study) by Garcia-Cabeza, Gomez, J.C., Sacristan, J.A., Edgell, E., de Chavez, M.Gonzalez, Gavart, S.

Get full text

P02.319 Antipsychotic treatment, adverse events and health-related quality of life by Badia, X., Casado, A., Sacristán, J.A., Gómez, J.C., Gregor, K.J., Gavart, S.

Get full text